Page last updated: 2024-08-23

pravastatin and valine

pravastatin has been researched along with valine in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (50.00)	29.6817
2010's	2 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fujino, A; Fujiwara, H; Hirano, M; Ieiri, I; Kitamura, Y; Kusuhara, H; Maeda, K; Otsubo, K; Sugiyama, Y; Watanabe, T; Yasuda, K	1
Fujimoto, M; Hashimoto, N; Imamura, H; Nakazawa, K; Ohta, T	1
Galetin, A; Houston, JB; Kenworthy, KE; Ménochet, K	1
Choi, H; Han, SH; Koh, KK; Lee, K; Lee, Y; Lim, S; Oh, PC; Quon, MJ; Sakuma, I; Shin, EK	1

Trials

2 trial(s) available for pravastatin and valine

Article	Year
Effects of organic anion transporting polypeptide 1B1 haplotype on pharmacokinetics of pravastatin, valsartan, and temocapril. Clinical pharmacology and therapeutics, 2006, Volume: 79, Issue:5 Topics: Adult; Animals; Antihypertensive Agents; Area Under Curve; Cells, Cultured; Cross-Over Studies; Dogs; Haplotypes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Liver-Specific Organic Anion Transporter 1; Male; Metabolic Clearance Rate; Organic Anion Transporters; Polymorphism, Genetic; Pravastatin; Tetrazoles; Thiazepines; Valine; Valsartan	2006
Combination pravastatin and valsartan treatment has additive beneficial effects to simultaneously improve both metabolic and cardiovascular phenotypes beyond that of monotherapy with either drug in patients with primary hypercholesterolemia. Diabetes, 2013, Volume: 62, Issue:10 Topics: Angiotensin II Type 1 Receptor Blockers; Body Mass Index; Brachial Artery; C-Reactive Protein; Coronary Artery Disease; Cross-Over Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Drug Therapy, Combination; Endothelium, Vascular; Female; Glycated Hemoglobin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Insulin Resistance; Lipids; Male; Middle Aged; Phenotype; Pravastatin; Tetrazoles; Treatment Outcome; Valine; Valsartan	2013

Article

Year

Effects of organic anion transporting polypeptide 1B1 haplotype on pharmacokinetics of pravastatin, valsartan, and temocapril.

Clinical pharmacology and therapeutics, 2006, Volume: 79, Issue:5

Topics: Adult; Animals; Antihypertensive Agents; Area Under Curve; Cells, Cultured; Cross-Over Studies; Dogs; Haplotypes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Liver-Specific Organic Anion Transporter 1; Male; Metabolic Clearance Rate; Organic Anion Transporters; Polymorphism, Genetic; Pravastatin; Tetrazoles; Thiazepines; Valine; Valsartan

2006

Combination pravastatin and valsartan treatment has additive beneficial effects to simultaneously improve both metabolic and cardiovascular phenotypes beyond that of monotherapy with either drug in patients with primary hypercholesterolemia.

Diabetes, 2013, Volume: 62, Issue:10

Topics: Angiotensin II Type 1 Receptor Blockers; Body Mass Index; Brachial Artery; C-Reactive Protein; Coronary Artery Disease; Cross-Over Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Drug Therapy, Combination; Endothelium, Vascular; Female; Glycated Hemoglobin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Insulin Resistance; Lipids; Male; Middle Aged; Phenotype; Pravastatin; Tetrazoles; Treatment Outcome; Valine; Valsartan

2013

Other Studies

2 other study(ies) available for pravastatin and valine

Article	Year
[Case report of cholesterol crystal embolism 1 month after carotid stenting]. No shinkei geka. Neurological surgery, 2007, Volume: 35, Issue:8 Topics: Aged; Angioplasty, Balloon, Coronary; Carotid Stenosis; Drug Therapy, Combination; Early Diagnosis; Embolism, Cholesterol; Humans; Male; Pravastatin; Prednisolone; Stents; Tetrazoles; Time Factors; Treatment Outcome; Valine; Valsartan	2007
Use of mechanistic modeling to assess interindividual variability and interspecies differences in active uptake in human and rat hepatocytes. Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:9 Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Benzimidazoles; Benzoates; Biological Transport; Bosentan; Carbamates; Dose-Response Relationship, Drug; Drug Interactions; Fluorobenzenes; Hepatocytes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemic Agents; Kinetics; Models, Biological; Organic Anion Transporters; Piperidines; Pravastatin; Pyrimidines; Quinolines; Rats; Rosuvastatin Calcium; Species Specificity; Sulfonamides; Telmisartan; Tetrazoles; Valine; Valsartan	2012

Article

Year

[Case report of cholesterol crystal embolism 1 month after carotid stenting].

No shinkei geka. Neurological surgery, 2007, Volume: 35, Issue:8

Topics: Aged; Angioplasty, Balloon, Coronary; Carotid Stenosis; Drug Therapy, Combination; Early Diagnosis; Embolism, Cholesterol; Humans; Male; Pravastatin; Prednisolone; Stents; Tetrazoles; Time Factors; Treatment Outcome; Valine; Valsartan

2007

Use of mechanistic modeling to assess interindividual variability and interspecies differences in active uptake in human and rat hepatocytes.

Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:9

Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Benzimidazoles; Benzoates; Biological Transport; Bosentan; Carbamates; Dose-Response Relationship, Drug; Drug Interactions; Fluorobenzenes; Hepatocytes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemic Agents; Kinetics; Models, Biological; Organic Anion Transporters; Piperidines; Pravastatin; Pyrimidines; Quinolines; Rats; Rosuvastatin Calcium; Species Specificity; Sulfonamides; Telmisartan; Tetrazoles; Valine; Valsartan

2012